Furthermore, high CD58 expression was associated with shorter disease-free survival (P value = 0.0086) and overall survival (P value = 0.0078), suggesting that CD58 was closely associated with HCC prognosis (Figures 7(c) and 7(d)). This evidence concerns the gene CD58 and hepatocellular carcinoma.